 |
ICON offers safety support across all stages of the product lifecycle by providing efficient drug safety processes, compiling concise drug safety profiles and developing tailored risk management strategies. |
| |
|
|
ICON's global safety team is comprised of over 300 medical
and safety experts and is focused on post-marketing drug
safety, pharmacovigilance and risk management. Our commitment
to quality is reflected in excellent audit ratings from
internal auditors, sponsors, and major regulatory authorities. |
| |
|
|
ICON is setting the standard for registry development and
execution by understanding and meeting the evolving
demands of global regulators and markets. Since 1990, we have successfully provided registry services in 18 countries
across six continents, with programs ranging from 10 to 2,000
sites, and from 45 to 2,000,000 patients. |
| |
|
|
The complex European regulatory safety requirements are
addressed by a team of 100 experts, located throughout
Europe, who are supported by the latest safety and regulatory
reporting tools and systems. This team provides a full range of
case management, QPPV, risk management services, signal
detection, PV plan design, and systems implementation. |
| |
|
|
ICON Medical & Safety has organically grown more than
30% per year (staff & revenue) over the last 5 years. |
| |
|
|
ICON will be hosting a series of webinars on Drug Safety Reporting, Regulations, and Risk starting May 2008. For more information, contact info@iconclinical.com. |
|
